DADC
LLY icon

D.A. Davidson & Co’s Eli Lilly LLY Stock Holding History

D.A. Davidson & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.3M Buy
52,466
+2,548
+5% +$2.58M 0.29% 65
2025
Q4 		$53.6M Buy
49,918
+1,730
+4% +$1.65M 0.33% 61
2025
Q3 		$36.8M Buy
48,188
+2,077
+5% +$1.55M 0.24% 71
2025
Q2 		$35.9M Buy
46,111
+2,211
+5% +$1.72M 0.25% 72
2025
Q1 		$36.3M Buy
43,900
+2,194
+5% +$1.83M 0.29% 60
2024
Q4 		$32.2M Sell
41,706
-2,187
-5% -$1.81M 0.26% 67
2024
Q3 		$38.9M Buy
43,893
+839
+2% +$754K 0.32% 56
2024
Q2 		$39M Buy
43,054
+2,027
+5% +$1.62M 0.35% 53
2024
Q1 		$31.9M Buy
41,027
+2,508
+7% +$1.78M 0.29% 63
2023
Q4 		$22.5M Buy
38,519
+4,240
+12% +$2.47M 0.22% 86
2023
Q3 		$18.4M Sell
34,279
-5,275
-13% -$2.72M 0.2% 90
2023
Q2 		$18.6M Buy
39,554
+2,357
+6% +$988K 0.2% 94
2023
Q1 		$12.8M Sell
37,197
-3,416
-8% -$1.15M 0.14% 113
2022
Q4 		$14.9M Buy
40,613
+1,411
+4% +$500K 0.18% 107
2022
Q3 		$12.7M Sell
39,202
-3,641
-8% -$1.15M 0.17% 112
2022
Q2 		$13.9M Buy
42,843
+25
+0.1% +$7.5K 0.17% 104
2022
Q1 		$12.3M Buy
42,818
+4,951
+13% +$1.27M 0.13% 124
2021
Q4 		$10.5M Buy
37,867
+4,664
+14% +$1.18M 0.11% 148
2021
Q3 		$7.67M Buy
33,203
+859
+3% +$212K 0.09% 177
2021
Q2 		$7.42M Sell
32,344
-8,506
-21% -$1.71M 0.09% 182
2021
Q1 		$7.63M Buy
40,850
+11,989
+42% +$2.35M 0.1% 166
2020
Q4 		$4.87M Buy
28,861
+448
+2% +$66.9K 0.07% 191
2020
Q3 		$4.21M Buy
28,413
+653
+2% +$101K 0.07% 189
2020
Q2 		$4.56M Sell
27,760
-3,002
-10% -$461K 0.09% 169
2020
Q1 		$4.27M Sell
30,762
-420
-1% -$57.7K 0.08% 181
2019
Q4 		$4.1M Buy
31,182
+1,670
+6% +$194K 0.07% 225
2019
Q3 		$3.3M Buy
29,512
+2,529
+9% +$282K 0.06% 253
2019
Q2 		$2.99M Sell
26,983
-1,722
-6% -$203K 0.06% 257
2019
Q1 		$3.64M Sell
28,705
-3,317
-10% -$403K 0.06% 244
2018
Q4 		$3.71M Buy
32,022
+874
+3% +$97.6K 0.07% 215
2018
Q3 		$3.34M Buy
31,148
+1,277
+4% +$128K 0.06% 254
2018
Q2 		$2.55M Sell
29,871
-3,705
-11% -$304K 0.05% 295
2018
Q1 		$2.6M Sell
33,576
-3,112
-8% -$251K 0.05% 275
2017
Q4 		$3.1M Buy
36,688
+1,070
+3% +$91K 0.07% 238
2017
Q3 		$3.05M Sell
35,618
-290
-0.8% -$23.8K 0.06% 269
2017
Q2 		$2.96M Buy
35,908
+411
+1% +$33.5K 0.07% 230
2017
Q1 		$2.98M Sell
35,497
-1,589
-4% -$127K 0.07% 224
2016
Q4 		$2.73M Sell
37,086
-3,923
-10% -$292K 0.06% 294
2016
Q3 		$3.29M Buy
41,009
+14,215
+53% +$1.14M 0.08% 229
2016
Q2 		$2.11M Buy
26,794
+2,995
+13% +$225K 0.06% 286
2016
Q1 		$1.71M Buy
23,799
+1,433
+6% +$108K 0.05% 308
2015
Q4 		$1.88M Buy
22,366
+3,998
+22% +$332K 0.06% 285
2015
Q3 		$1.54M Buy
18,368
+3,049
+20% +$257K 0.05% 310
2015
Q2 		$1.28M Sell
15,319
-4,691
-23% -$357K 0.04% 358
2015
Q1 		$1.45M Sell
20,010
-19,965
-50% -$1.42M 0.05% 325
2014
Q4 		$2.76M Buy
39,975
+2,304
+6% +$156K 0.09% 227
2014
Q3 		$2.44M Buy
37,671
+105
+0.3% +$6.65K 0.08% 234
2014
Q2 		$2.33M Buy
37,566
+3,406
+10% +$203K 0.08% 249
2014
Q1 		$2.01M Sell
34,160
-9,342
-21% -$521K 0.07% 267
2013
Q4 		$2.22M Buy
43,502
+13,226
+44% +$662K 0.08% 236
2013
Q3 		$1.52M Sell
30,276
-535
-2% -$28K 0.07% 263
2013
Q2 		$1.51M Buy
+30,811
New +$1.68M 0.07% 250

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.A. Davidson & Co's LLY Position: Q1 2026 in Review

D.A. Davidson & Co increased its Eli Lilly (LLY) stake by 5.1% in Q1 2026, buying an estimated $2.58M and bringing the position to 52,466 shares worth $48.3M. The position accounts for 0.29% of the portfolio, ranked #65.

D.A. Davidson & Co first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $53.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • D.A. Davidson & Co held 52,466 shares of Eli Lilly worth $48.3M as of Q1 2026.
  • D.A. Davidson & Co bought 2,548 Eli Lilly shares in Q1 2026, an estimated $2.58M.
  • Eli Lilly made up 0.29% of D.A. Davidson & Co's portfolio in Q1 2026, its #65 holding.
  • D.A. Davidson & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • D.A. Davidson & Co's Eli Lilly position peaked at $53.6M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.